Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese University Hospital

Journal of Clinical Microbiology

Volumn 50, Issue 2, 2012, Pages 223-226

  Yang, Fu Chen ^a   Yan, Jing Jou ^c   Hung, Kuei Hsiang ^a   Wu, Jiunn Jong ^a,b,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BETA LACTAMASE; BETA LACTAMASE AMPC; BETA LACTAMASE SHV12; BETA LACTAMASE TEM 1; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; UNCLASSIFIED DRUG;

ACRB GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BETA LACTAMASE GENE; CLONAL VARIATION; CONTROLLED STUDY; ENTEROBACTER CLOACAE; GENETIC VARIABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION PROFILING; GENOTYPE; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TAIWAN;

ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE;

EID: 84862908913     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01263-11     Document Type: Article

References (28)

1. Bell JM, Turnidge JD, Jones RN, the Asia-Pacific Participants SENTRY. 2003. Prevalence of extended-spectrum β-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001. Antimicrob. Agents Chemother. 47:3989-3993. (Pubitemid 37485024)
2. Bennett JW, Herrera ML, Lewis JS II, Wickes BW, Jorgensen JH. 2009. KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient. Antimicrob. Agents Chemother. 53:292-294.
3. Biendo M, et al. 2008. Molecular typing and characterization of extended-spectrum TEM, SHV and CTX-M beta-lactamases in clinical isolates of Enterobacter cloacae. Res. Microbiol. 159:590 -594.
4. Biendo M, et al. 2008. Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital. J. Clin. Microbiol. 46:1037-1044. (Pubitemid 351379998)
5. Castanheira M, et al. 2011. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob. Agents Chemother. 55:1274 -1278.
6. Chen YH, et al. 2011. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intraabdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J. Infect. 62:280 -291.
7. Clinical and Laboratory Standards Institute. 2009. Performance standards for antimicrobial disk susceptibility tests; M02-A10, approved standard, 10th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; M07-A8, approved standard, 8th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial susceptibility testing, 21st informational supplement, M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
10. Cornaglia G, Russell K, Satta G, Fontana R. 1995. Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Antimicrob. Agents Chemother. 39:350 -355.
11. Doumith M, Ellington MJ, Livermore DM, Woodford N. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63:659-667.
12. Falcone M, et al. 2009. Infections with VIM-1 metallo-β-lactamase- producing Enterobacter cloacae and their correlation with clinical outcome. J. Clin. Microbiol. 47:3514 -3519.
13. Lee CC, et al. 2010. Bacteremia due to extended-spectrum-beta-lactamase- producing Enterobacter cloacae: role of carbapenem therapy. Antimicrob. Agents Chemother. 54:3551-3556.
14. Pagès JM, Masi M, Barbe J. 2005. Inhibitors of efflux pumps in Gram-negative bacteria. Trends Mol. Med. 11:382-389. (Pubitemid 41080580)
15. Piddock LJ. 2006. Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. Microbiol. 4:629-636. (Pubitemid 44317025)
16. Pournaras S, et al. 2005. Spread of efflux pump-overexpressing, non-metallo-beta-lactamase-producing, meropenem-resistant but ceftazidime-susceptible Pseudomonas aeruginosa in a region with blaVIM endemicity. J. Antimicrob. Chemother. 56:761-764. (Pubitemid 41487780)
17. Queenan AM, Bush K. 2007. Carbapenemases: the versatile beta-lactamases. Clin. Microbiol. Rev. 20:440-458.
18. Rodríguez-Martínez JM, Poirel L, Nordmann P. 2009. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:4783- 4788.
19. Rodriguez-Villalobos H, et al. 2011. Trends in production of extendedspectrum beta-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals. J. Antimicrob. Chemother. 66:37- 47.
20. Sanders WE, Jr, Sanders CC. 1997. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin. Microbiol. Rev. 10:220 -241.
21. Szabó D, et al. 2006. Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae. Antimicrob. Agents Chemother. 50:2833-2835.
22. Tenover FC, et al. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
23. Tzelepi E, et al. 2000. Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J. Clin. Microbiol. 38:542-546. (Pubitemid 30082638)
24. Woodford N, et al. 2007. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 29:456-459. (Pubitemid 46349596)
25. Yan JJ, Ko WC, Chuang CL, Wu JJ. 2002. Metallo-beta-lactamaseproducing Enterobacteriaceae isolates in a university hospital in Taiwan: prevalence of IMP-8 in Enterobacter cloacae and first identification of VIM-2 in Citrobacter freundii. J. Antimicrob. Chemother. 50:503-511.
26. Yan JJ, Wu JJ, Tsai SH, Chuang CL. 2004. Comparison of the double-disk, combined disk, and Etest methods for detecting metallobeta-lactamases in gram-negative bacilli. Diagn. Microbiol. Infect. Dis. 49:5-11.
27. Yang Q, et al. 2010. Surveillance of antimicrobial susceptibility of aerobic and facultative Gram-negative bacilli isolated from patients with intraabdominal infections in China: the 2002-2009 Study for Monitoring Antimicrobial Resistance Trends (SMART). Int. J. Antimicrob. Agents 36:507-512.
28. Yu WL, et al. 2006. Characterisation and molecular epidemiology of extended-spectrum β-lactamase-producing Enterobacter cloacae isolated from a district teaching hospital in Taiwan. Clin. Microbiol. Infect. 12:579-582.